Beijiajie (603059): The comprehensive competitiveness of leading oral care companies continues to improve
Beijiajie (603059): Q3 revenue grew steadily and continued to further cultivate oral health
Beijiajie (603059): The main business of Q3 foundry is growing steadily and is optimistic about endogenous epitaxial growth space
Beijiajie (603059): Endogenous and epitaxial go hand in hand
Beijiajie (603059) 2024 Semi-Annual Report Review: Steady growth in the main dental care industry, investment income affects profit performance
Beijiajie (603059): Steady growth in main business, increasing investment by holding subsidiaries dragging down profits
Beijiajie (603059): Q2 revenue growth momentum is improving, focus on endogenous and epitaxial collaborative development
Beijiajie (603059) review: The fundamentals of the main business have improved and entered the high-growth probiotic circuit!
Beijiajie (603059): The 1Q24 business momentum is positive, and there is room for endogenous and epitaxial development
Open Source Securities released a research report on April 25 stating that it gave a buy rating to Double Clean (603059.SH). The main reasons for the rating include: 1) the impact of overseas customer inventory removal gradually diminished, and net profit
Guoyuan Securities released a research report on April 24 stating that it gave Beijiajie (603059.SH) an increase in holdings rating. The main reasons for the rating include: 1) 24Q1 profit increased 164.53% year-on-year, with an annual revenue growth targ
Beijiajie (603059): The main business momentum in 24Q1 opens the ceiling of growth to positive epitaxial mergers and acquisitions
Beijiajie (603059) 2023 Report & 2024 Quarterly Report Comment: 24Q1 performance exceeded expectations, main business fundamentals reversed!
Beijiajie (603059): Steady upward expansion of the main business opens up room for growth
Beijiajie (603059): 24Q1 revenue growth, beautiful endogenous epitaxial growth
Beijiajie (603059): Strong Q1 performance growth continues to deepen oral health
Pejiajie (603059) 2023 and 2024 Quarterly Report Annual Report Review: 24Q1 profit growth rate is impressive, and the layout is further extended
Beijiajie (603059): Resonance in the OEM business improves endogenous and epitaxial co-drives growth
Beijiajie (603059): Adhere to the “endogenous growth+epitaxial development” strategic expansion momentum determination
Beijiajie (603059): Oral care foundry leader with endogenous epitaxial integration to enhance oral health